Companies: 10,795·Total market cap: $144.5T
ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc.

ORICNASDAQHealthcare● Active
$7.53
+$0.03(+0.40%)
Market Cap$779487242
P/E Ratio
52W High$14.93
52W Low$7.23
Overview

ORIC Pharmaceuticals, Inc. (ORIC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ORIC · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.44oric eps ttm · oric earnings per shareEarnings history
PE Ratio (TTM)oric pe ratio ttm · oric price to earningsPE Ratio deep dive
Revenue (TTM)0.00oric revenue ttm · oric annual revenueFull revenue history
Dividend YieldNo Dividenddoes oric pay dividends · oric dividend yieldDividend history
Shares Outstanding87.8Moric shares outstanding · oric floatShares outstanding history
Next EarningsAug 11, 2026Est.oric earnings date · oric next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
oric pharmaceuticals, inc. revenue · oric revenue 2025
FY 2025Net Income-$129.5M▼ 1.27% YoY
202320242025
oric pharmaceuticals, inc. net income · oric profit 2025
FY 2025EPS$-1.47▲ +19.67% YoY
202320242025
oric eps · oric pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$135.2MEPS: $-1.44View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis oric a buy · oric analyst rating
Strong Buy
0
Buy
10
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$15.00Low
$7.53Current
$19.25Avg Target155.64% upside
$25.00High
oric price target · oric 12 month forecast

Total: 10 · Buy rate: 100.0%

The ORIC analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $19.25, representing +155.64% upside from the current price of $7.53.

Stock Performance

Full History
1D+0.40%
1W-0.66%
1M-14.92%
3M-45.08%
YTD-7.95%
1Y-23.63%
5Y-62.05%

About ORIC Pharmaceuticals, Inc.

CEOJacob Chacko
IPO DateApr 24, 2020
Employees122
CountryUS

ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's …

what is oric pharmaceuticals, inc. · oric stock overview · oric pharmaceuticals, inc. company profile · who is oric pharmaceuticals, inc. ceo · oric NASDAQ · oric pharmaceuticals, inc. headquarters · oric pharmaceuticals, inc. business segments

About Stock Overview & Key Data

ORIC Pharmaceuticals, Inc. (ORIC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 24, 2020. As of the latest trading session, ORIC stock price is $7.53, with a market capitalization of $779.5M. The stock has returned -23.63% over the past 12 months and -7.95% year-to-date.

According to 10 Wall Street analysts, the consensus rating for ORIC Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $19.25. In fiscal year 2025, ORIC Pharmaceuticals, Inc. reported revenue of — and net income of -$129.5M. For detailed data — including ORIC Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, ORIC Pharmaceuticals, Inc. (ORIC) stock price is $7.53. The stock is traded on NASDAQ under the ticker symbol ORIC. The 52-week range is $7.23 – $14.93.

ORIC stock priceORIC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice